VCR ventracor limited

issue shares to abn-----$2.20???????

  1. 5,609 Posts.
    The next Cochlear success story or the next Biota calamity? Shares in artificial heart-device maker Ventracor have been on the rise, up 3.3 per cent to $3.15 yesterday, and last night the group was seeking to issue 12 million new shares through ABN Amro Morgans.

    The price might be as low as $2.20 given the stock was trading at $2.02 on August 15.

    Last week, the first patient to receive its VentrAssist device, a man in his early 70s, was released from Melbourne's Alfred Hospital and is still OK. Presumably the funds are to help pay for continuing clinical trials and marketing efforts. A further $12 million rights issue is possibly going to follow the placement.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.